|
|
||||||||||||||
|
|
|||||||||||||||
Aetiology |
Clinical impact ratings GP/FP/Primary care






IM/Ambulatory care 





Emergency Medicine 





Neurology 





Geriatrics 





Key Words: diuretics angiotensin-converting enzyme inhibitors lithium
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
population based, nested, case control study with analysis of multiple linked healthcare databases over 10 years.
Setting:
Ontario, Canada.
Patients:
10 615 patients
66 years of age (mean age 72 y, 62% women) who were receiving uninterrupted lithium treatment and resided in Ontario, Canada.
Assessment of risk factors:
use of diuretic (alone or in combination with another agent), ACE inhibitor, or prescription NSAID (including cyclooxygenase 2 inhibitors). Thiazide type and loop diuretics were examined separately.
Outcome:
hospital admission with diagnosis of lithium toxicity within 28 days of exposure.
MAIN RESULTS
413 patients (3.9%) had
1 hospital admission for lithium toxicity. After adjustment for potential confounders, patients treated with a loop diuretic or ACE inhibitor in the preceding 28 days had modest increased risk of hospital admission for lithium toxicity (table
); these increased risks were particularly high among patients newly treated with loop diuretics or ACE inhibitors in the preceding 28
Maurice Laville, MD
Université Claude Bernard, Hôpital Edouard-Herriot
Lyon, Cedex, France
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |